Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Sterling Biotech Bank...

    Sterling Biotech Bank Fraud: ED seize assets including business jet, ships, oil rings worth over Rs 9700 crore

    Farhat NasimWritten by Farhat Nasim Published On 2019-06-27T09:45:43+05:30  |  Updated On 27 Jun 2019 9:45 AM IST
    Sterling Biotech Bank Fraud: ED seize assets including business jet, ships, oil rings worth over Rs 9700 crore

    New Delhi: Gujarat-based Sterling Biotech is in for more trouble as probe agency, Enforcement Directorate(ED) has recently issued a provisional order for attachment of assets worth over Rs 9700 crore as part of its bank fraud and money laundering probe against the pharmaceutical firm.


    The seized assets include Oil rigs in Nigeria, ships, a business jet and a plush flat in London.


    According to a report by PTI, the Enforcement Directorate said it has issued a provisional order under the Prevention of Money Laundering Act (PMLA) for attachment of these properties.


    This is one of the biggest attachment of assets order issued by the agency and in this, most of the properties attached are based abroad, a senior official said, adding that the total value is Rs 9,778 crore.


    Four oil rigs and an oil field named OML143 in Nigeria, four Panama registered ships --'Tuljabhawani', 'Varinda', 'Bhavya' and 'Brahmanietc', a gulf stream jet registered in the US and held in the name of SAIB LLC, and a residential flat in London have been attached, the federal probe agency said in a statement.


    The holding company of the ships is Atlantic Blue Water Services, it said


    The alleged Rs 8,100 crore bank loan fraud is being alleged to have been perpetrated by the Vadodara-based pharma firm and its main promoters Nitin Sandesara, Chetan Sandesara and Deepti Sandesara, all of whom are absconding.

    The Sandesaras are also under probe for their alleged nexus with some high-profile politicians by the ED as also by the CBI and the Income Tax Department under criminal sections that deal with corruption and tax evasion respectively.


    The ED, in the past, has attached assets worth Rs 4,730 crore in this case.


    "The main promoters (of the Sterling group) have not only siphoned off loan funds to finance their Nigerian oil business but also for their personal purposes," the agency said.


    It said loan funds were "diverted for non-mandated purposes, layered and laundered through a web of multiple domestic as well as offshore entities."




    "Investigations revealed that the group was engaged in round-tripping of standby letters of credit (SBLCs) funds to the tune of Rs 4,500 crore by violating conditions laid by the RBI while sanctioning the loan," the ED said.


    It is alleged that the company took loans of over Rs 5,383 crore from a consortium led by Andhra Bank, which had turned into non-performing assets.


    The total volume of the alleged loan defraud is pegged at Rs 8,100 crore.


    "The said SBLCs were later on devolved on the guarantor banks causing wrongful loss to these public sector banks and to the public at large. Their strategy included incorporation of multiple shell companies, conducting circular transactions to artificially inflate turnover of flagship companies, claiming higher depreciation on non-existing machinery to avoid tax liabilities, artificial share trading with the shell companies, layering and laundering of proceeds of crime within India and abroad through the web of multiple shell companies," the ED alleged.


    It charged that the "promoters (Sandesaras) incorporated 249 domestic and 96 offshore shell companies" to execute the alleged bank loan scam.


    The ED registered a criminal case in the alleged bank loan fraud case based on a Central Bureau of Investigation FIR and charge sheet.


    The promoters of the firm, also alleged to be the main conspirators of the bank fraud apart from their employees and bank executives, are absconding and have been reported to be based in the Nigera from where India is trying to extradite them.


    Also Read: Court allows ED to seek assistance from 21 countries in Sterling Biotech bank fraud case

    bank fraudbank fraud caseCBI)EDEnforcement DirectorateIncome Tax DeptLondonpharmapharma newspharma news indiaPMLA caseSandesarassterlingSterling BiotechSterling Biotech PMLA case
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok